Loading article...
Loading article...
Stream/Area:
-
Subject:
-
Paper ID:
IJSREM57079
Volume:
10 |
2 |
Feb 2026
Pages:
Publication Frequency:
Monthly (12 issues per year)
License:International Journal of Scientific Research in Engineering and Management follows the Creative Commons Attribution 4.0 (CC BY 4.0) License, allowing free use and distribution with proper attribution.
The Accurate segmentation and volumetric analysis of liver tumors from computed tomography (CT) scans are essential for early diagnosis, treatment planning, and longitudinal assessment of hepatic malignancies. Manual tumor delineation is not only time-consuming but also susceptible to inter- and intra-observer variability, which can affect clinical consistency and treatment outcomes. Automated and robust segmentation methods are therefore highly desirable in modern clinical workflows. This paper proposes an AI-based framework for automated three-dimensional (3D) liver tumor segmentation and volumetric analysis using deep learning. The framework is designed to process full CT volumes and to accurately identify tumor regions despite variations in tumor size, shape, and contrast. By leveraging volumetric learning, the proposed approach preserves spatial continuity across slices, leading to improved segmentation performance compared to conventional two-dimensional methods. Comprehensive preprocessing steps, including intensity normalization, resampling, and noise reduction, are applied to standardize CT data and enhance model generalization. A 3D convolutional neural network architecture is employed to extract multi-scale features that capture both fine-grained tumor boundaries and broader anatomical context. Post-processing strategies such as morphological operations and connected component analysis are utilized to refine segmentation outputs and reduce false detections. Based on the generated 3D segmentation masks, volumetric analysis is conducted to compute tumor volume and related quantitative metrics. These measurements provide objective indicators for tumor burden evaluation, disease progression monitoring, and treatment response assessment, enabling more informed clinical decision-making and personalized therapy planning.
KEYWORDS
Publication Date
1/2/2026
Peer Review Type
Double-Blind Peer Review
Review Rounds: 2
Documents
Article Views
0
Total views since publication
PDF Downloads
2
Total downloads since publication
Geographic Reach
5
Digital Preservation: This article is permanently archived on Zenodo and complies with all data preservation standards across major indexing platforms.
Plagiarism Screening
This manuscript has been checked for plagiarism using TurnitinPlagiarismChecker software.
Conflict of Interest
The authors declare no conflict of interest related to this research work.
Funding Information
No funding information available for this research.
Related research in the same subject area
Loading similar articles...